Oralin (Sertraline)

Oralin (sertraline) acts on the serotonergic pathway and is indicated for several psychiatric conditions.

• Major depressive disorder: alleviates depressive symptoms and improves mood.
• Obsessive‑compulsive disorder: reduces intrusive thoughts and compulsive behaviors.
• Panic disorder: decreases frequency and severity of panic attacks.
• Social anxiety disorder: lessens fear of social situations and improves functioning.
• Post‑traumatic stress disorder: helps control re‑experiencing symptoms and hyperarousal.

• Sertraline selectively inhibits the serotonin transporter (SERT), blocking reuptake of serotonin into presynaptic neurons. This increases extracellular serotonin levels in the central nervous system, enhancing serotonergic neurotransmission and contributing to mood stabilization and anxiety reduction.

Sertraline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild stomach upset that often improves with continued use.
• Headache: occasional tension‑type headache.
• Insomnia: difficulty falling or staying asleep.
• Dry mouth: reduced salivation.
• Diarrhea: loose stools.
• Sexual dysfunction: decreased libido or difficulty achieving orgasm.

Serious or Rare Side Effects

• Serotonin syndrome: agitation, hyperthermia, muscle rigidity, and autonomic instability.
• Suicidal thoughts: emergence of new or worsening suicidal ideation, especially early in treatment.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Hyponatremia: low blood sodium presenting with confusion or weakness.
• Abnormal bleeding: increased bruising or prolonged bleeding time.

When prescribing sertraline, clinicians should consider several safety aspects.

• Pregnancy: discuss potential risks and benefits; limited data suggest careful use may be warranted.
• Breastfeeding: sertraline passes into milk; evaluate infant risk versus maternal benefit.
• Drug‑induced QT prolongation: monitor in patients with cardiac risk factors.
• Hepatic impairment: dose adjustment may be needed in severe liver disease.
• Concomitant serotonergic agents: avoid combined use to reduce serotonin syndrome risk.
• Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Sertraline interacts with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.
• Pimozide: can cause severe cardiac effects.
• Triptans: increased serotonin syndrome potential.

Moderate Interactions (Monitor Closely)

• NSAIDs and anticoagulants: heightened bleeding risk.
• Antiplatelet agents: may increase bruising.
• CYP2C19 inhibitors (e.g., fluoxetine): may raise sertraline levels.
• Alcohol: may enhance CNS depression.
• Other serotonergic antidepressants: require dose adjustments and monitoring.